AFP and hepatocellular carcinoma: It should be noted that the combination of plasma FBXL19-AS1 and AFP could significantly improve the diagnosis for HCC, suggesting that FBXL19-AS1 could serve as a biomarker for the auxiliary diagnosis of HCC.